Compound ID | 2951
NP108 (Luminaderm)
Synonym(s): NP-108 | NP 108
Class: Antimicrobial peptide
| Spectrum of activity: | Gram-positive |
| Details of activity: | Active against methicillin-resistant and -susceptible Staphylococcus aureus (including additionally mupirocin-resistant strains) and Staphylococcus epidermidis; membrane-active agent |
| Description: | Synthetic compound; developed for topical use for nasal decolonisation |
| Institute where first reported: | NovaBiotics Ltd., Craibstone, Aberdeen, United Kingdom |
| Year first mentioned: | 2017 |
| Highest developmental phase: | Preclinical |
| Development status: | Experimental |
| External links: | |
| Citation: | https://journals.asm.org/doi/10.1128/aac.00502-17 |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.